BioElectronics Announces Drug Free Solution to the Opioid

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
472
BioElectronics Announces Drug Free Solution to the Opioid Crisis (ActiPatch)

FREDERICK, MD--(Marketwired - Nov 6, 2017) - BioElectronics Corporation ( OTC PINK : BIEL ), the maker of advanced consumer pain management medical device, ActiPatch, today announced that it has taken on the responsibility to find a DRUG-FREE solution to the Opioid Crisis.

The reach of the opioid crisis now stretches wide and far, claiming an American life every 9 minutes. While there may be many policy solutions to mitigate the crisis, there is an urgent need to deploy solutions that can save as many lives as possible. At least half of all opioid-related deaths involve a prescription opioid, revealing a chilling fact: the opioid crisis is being fueled by the lack of a safe alternative for chronic pain.

Providing a non-prescription, safe intervention for chronic pain can prevent the risky journey of prescription opioid medication, and thus overdose deaths. Up to 85% of chronic pain is musculoskeletal in nature, i.e., knee pain, back pain, neck pain etc. There is credence in deducing that a solution for chronic musculoskeletal pain can serve as the first line of defense against opioid abuse. We propose below, an American solution built by a small company.

The ActiPatch® Musculoskeletal Pain Therapy is a wearable medical device that is FDA cleared for non-prescription use. There is clinical evidence that in the UK, where a similar opioid crisis is unfolding, ActiPatch users reported:

  • Reduced opioid pain medication use by 33%
  • Reduced other prescription pain medication use by 65%
  • Reduced pain level by 57%
  • Reduced side effects from overall pain medication usage

Here's our solution: A FREE ActiPatch 7-Day Trial for the first 5,000 pain sufferers at www.tryActiPatch.com with the promo code NOPAIN2017. Our hope is to expose consumers to an alternative to opioids and other analgesics that is user friendly, without side effects, and actually WORKS!

About BioElectronics Corporation

BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy. For more information, please visit www.bielcorp.com .

Paul Knopick E & E Communications 940.262.3584

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Important Update for James Hardie Shareholders - Act Now

Updated Category News Views 232

Significant Notice for James Hardie Investors Attention to all investors in James Hardie Industries plc (NYSE: JHX). If you have incurred losses exceeding $100,000 from your investments, you need to be informed about an important opportunity. The deadline for filing lead plaintiff applications in the class action lawsuit is approaching rapidly. Class Action Lawsuit...

Continue Reading
Honoring Exceptional Literature: 2025 Literary Awards Finalists

Updated Category News Views 192

Celebrating Literary Excellence in Canada Each year, the prestigious Governor General's Literary Awards recognize outstanding works in Canadian literature, and 2025 is no exception. The Canada Council for the Arts proudly announces the finalists for this year’s awards. The competition spotlights a remarkable collection of literary achievements across seven categories,...

Continue Reading
Innovative AI Cabin Platform to Transform Mobility Experiences

Updated Category News Views 239

Innovative AI Cabin Platform to Transform In-Vehicle Experiences LG Electronics is stepping into the future of transportation by unveiling its cutting-edge AI Cabin Platform at CES 2026. This platform represents the forefront of mobility technology, powered by the Snapdragon Cockpit Elite platform, and emerges as a part of LG's vision for an AI-defined vehicle (AIDV)....

Continue Reading
Understanding Share Information and Voting Rights at Voltalia

Updated Category News Views 67

Total Shares and Voting Rights Overview In the dynamic world of finance, keeping track of a company's share capital and voting rights is essential for investors. Recently, Voltalia, a significant player in the renewable energy sector, shared pertinent information concerning its total number of shares and the associated voting rights. This data helps stakeholders...

Continue Reading
Opportunities in Hospitality: Invest in Canwill Holdings

Updated Category News Views 115

Investment Opportunity for Canwill Holdings (Pvt) Ltd The Government of Sri Lanka is inviting expressions of interest for the divestiture of its complete shareholding in Canwill Holdings (Pvt) Ltd. Canwill stands as the parent company of prestigious brands such as Sinolanka Hotels & Spa and Helanco Hotels & Spa. Government Involvement and Advisory Role This initiative is...

Continue Reading